Insulin-like Growth Factor-1 Levels Reflect Muscle and Bone Health and Determine Complications and Mortality in

Parminder Kaur1, Nipun Verma1, Aishani Wadhawan1

  • 1Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, India.

Insights

Reduced insulin-like growth factor 1 (IGF-1) levels in cirrhosis patients are linked to sarcopenia, frailty, and poor outcomes. Lower IGF-1 indicates higher complication risk and mortality, but increases suggest better survival.

Area of Science:

  • Endocrinology
  • Hepatology
  • Geriatrics

Background:

  • The growth hormone-insulin-like growth factor (GH-IGF-1) axis is crucial but its role in cirrhosis complications like sarcopenia, frailty, and bone health is unclear.
  • Understanding GH-IGF-1 axis impairment is vital for managing cirrhosis prognosis.

Purpose of the Study:

  • To investigate the association between serum GH and IGF-1 levels and clinical outcomes in adult decompensated cirrhosis outpatients.
  • To determine the predictive value of IGF-1 for complications and 180-day mortality in cirrhosis.

Main Methods:

  • Serum GH and IGF-1 levels were measured in 172 adult decompensated cirrhosis outpatients.
  • Associations were analyzed with sarcopenia (CT-SMI), liver frailty index (LFI), osteodystrophy (DEXA), clinical decompensations, and 180-day survival.
  • The predictive accuracy of IGF-1 for mortality was compared with MELD-Na scores.

Main Results:

  • Lower IGF-1 levels correlated with sarcopenia, osteodystrophy, higher LFI, CTP, and MELD-Na scores (P < 0.05).
  • Patients with low IGF-1 had increased overall complications, ascites, and encephalopathy (P < 0.05).
  • IGF-1 and MELD scores independently predicted 180-day mortality, with combined IGF-1 and MELD-Na improving prediction accuracy (AUC 0.729).

Conclusions:

  • Reduced IGF-1 levels are a marker for sarcopenia, frailty, and osteodystrophy in cirrhosis.
  • Low IGF-1 is associated with increased disease severity, complications, and mortality in cirrhosis patients.
  • Increasing IGF-1 levels during follow-up correlate with improved survival and reduced complications.
Abstract

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.1K
Liver Physiology01:30

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
454
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
156
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
207
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.2K